2023年6月2日

阿波羅發射新一代平台快速見解在衛生保健和生命科學解決方案反映了阿波羅的持續投資加速健康核心技術創新,推動機器學習和人工智能5月31日,2023年東部時間上午09:00水城,質量。——(業務線)——阿波羅(Apollo)情報,實時全局數據和見解的領先供應商的保健和生命科學行業,宣布推出新一代的市場洞察力技術平台支持快速的見解和數據收集在醫療保健和生命科學產業。先進的平台是推動公司的持續投資在其核心技術,推動機器學習(毫升)和人工智能(AI)。“阿波羅已經多年,數百萬美元的旅程建築朝著這一時刻,我們的投資數據和技術將使我們能夠利用先進的機器學習和數據科學應用,為我們的客戶提供無與倫比的服務體驗”與現代企業數據架構,用一流的技術,阿波羅的下一代平台為客戶提供高級功能來支持他們進步的洞察力和數據需求。平台使用毫升抽樣情報達到全球醫療專業(HCP)的小組成員具有較高的效率,提供正確的研究機會HCP利益相關者,在正確的地點和時間。這個新的、先進的能力培養目標的無縫循環交互和持續的接觸,使大speed-to-insight和更高質量的數據。對於學校來說,阿波羅的增強路由功能意味著他們獲得更多相關和匹配機會分享他們的專業知識和擴大他們的聲音。功能目前推出測試版包括:自然語言處理(NLP)進步在開放標簽文本分析,編碼,ML-enhanced不良事件(AE)檢測和報告。ML-based謝禮優化麵板接觸。動態分析和驗證。 In the second half of 2023, these foundational capabilities will support further ML and AI advancements focused on sentiment analysis for free text, survey automation, and expanded global capabilities. “Apollo has been on a multi-year, multimillion-dollar journey building towards this moment when our investments in data and technology would allow us to take advantage of advances in machine learning and data science applications to provide our clients with an unmatched service experience,” said Daniel S. Fitzgerald, president and CEO of Apollo Intelligence. “Life science companies will be able to see the immediate impact in speed and data quality as we leverage machine learning to intelligently sample our HCP communities for data collection. These advances are just the beginning for Apollo as we continue our innovative journey and extend our robust roadmap to deliver higher quality data, speed-to-insight, and advanced analytics and data visualization for our clients.” Apollo has made sizable investments in its platform since 2019 in anticipation of this launch. Its relationship with Frazier Healthcare Partners, in June 2022, has accelerated investment in these areas, with Frazier and Apollo sharing a vision for technological innovation within the healthcare data and insights market. The Frazier Data and AI Center of Excellence has been an instrumental partner in rapidly advancing these modern elements and realizing Apollo’s technology vision. Apollo Intelligence Apollo’s mission is to accelerate health innovation to improve life. In 2019, Apollo launched with the acquisition of InCrowd , a pioneer of real-time, automated insights for the life science industry. In 2020, Apollo strengthened its global reach by acquiring Survey Healthcare Global , a global market leader of first-party healthcare data collection and custom survey solutions. Apollo provides access to 2 million healthcare stakeholders worldwide—including physicians, patients, caregivers, and allied healthcare professionals. Apollo’s 250+ employees support top global pharmaceutical brands, market research agencies, and consultancies across 13 different countries in the Americas, Europe, and Asia. Apollo is a portfolio company of Frazier Healthcare Partners . For more information about Apollo, please visit our website at www.apollointelligence.net . Contacts